Bayer Confident CureVac COVID Pact Will Be A Success

Plans To Deliver mRNA Vaccine On Track

 
• By Kevin Grogan

CEO Werner Baumann admits he was skeptical at first as to whether the German group had the necessary know-how to manufacture vaccines but the firm's expertise in the development of biotech products has strengthened his belief Bayer can deliver.

Administration of the research and development center from the Pharmaceuticals Division in Wuppertal
Bayer's Wuppertal Site Where CureVac's vaccine will be made • Source: Archive

More from COVID-19

More from Scrip